Atlas Trials

Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma

Clinical trial NCT02592876 · TERMINATED

Trial details

NCT number
NCT02592876
Sponsor
Seagen Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma, B-cellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular, Grade 3bFollicular Lymphoma, Grade 3b
Start date
2015-10-01
Primary completion
2018-04-20
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.